Chad vs Morocco: Antiretroviral therapy coverage for PMTCT
Chad
77.0%
in 2024
Morocco
72.0%
in 2024
Chad rank
46th
Morocco rank
49th
Antiretroviral therapy coverage for PMTCT over time
- Chad
- Morocco
How they compare
Chad currently reports 77.0% against 72.0% in Morocco, a difference of 5.0%.
That makes Chad's figure about 1.1 times Morocco's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Morocco ahead.
Chad ranks 46th and Morocco ranks 49th of 84 countries.
Across the 3 decades both report, Chad averaged higher in 2 and Morocco in 1.
Head to head by decade
| Decade | Chad | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.6% | 3.9% | 1.3% | Morocco |
| 2010s | 51.0% | 34.4% | 16.6% | Chad |
| 2020s | 80.0% | 55.8% | 24.2% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Chad or Morocco?
- Chad, at 77.0% against 72.0% in Morocco as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Chad and Morocco?
- 5.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Morocco?
- 25 years are reported by both, from 2000 to 2024.
- How do Chad and Morocco rank globally for antiretroviral therapy coverage for pmtct?
- Chad ranks 46th and Morocco ranks 49th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).